In Vitro Antimicrobial Activity of Doripenem, a New Carbapenem
Open Access
- 1 April 2004
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (4) , 1384-1396
- https://doi.org/10.1128/aac.48.4.1384-1396.2004
Abstract
The doripenem MICs at which 90% of the tested strains were inhibited ranged from 0.03 to 1 μg/ml for 10 species of Enterobacteriaceae ( n = 351), from 0.03 to 0.12 μg/ml for oxacillin-susceptible staphylococci ( n = 119), from 4 to 32 μg/ml for oxacillin-resistant staphylococci ( n = 64), from ≤0.008 to 0.06 μg/ml for penicillin-susceptible streptococci ( n = 132), and from 1 to 4 μg/ml for penicillin-resistant streptococci ( n = 51). Overall, doripenem demonstrated in vitro activity similar to that of meropenem against gram-negative pathogens and to that of imipenem against gram-positive pathogens.Keywords
This publication has 8 references indexed in Scilit:
- Antimicrobial-induced release of endotoxin from Pseudomonas aeruginosa: comparison of in vitro and animal modelsJournal of Antimicrobial Chemotherapy, 2003
- In VitroAntibacterial Activity of S-4661, a New Parenteral Carbapenem, against Urological Pathogens Isolated from Patients with Complicated Urinary Tract InfectionsJournal of Chemotherapy, 2002
- Comparative in vitro Activity of S-4661, a New Parenteral Carbapenem, and Other Antimicrobial Agents against Respiratory PathogensChemotherapy, 2000
- In Vitro and In Vivo Antibacterial Activities of CS-834, a New Oral CarbapenemAntimicrobial Agents and Chemotherapy, 1998
- In Vitro and In Vivo Antibacterial Activities of S-4661, a New CarbapenemAntimicrobial Agents and Chemotherapy, 1998
- Comparative stability of carbapenem and penem antibioties to human recombinant dehydro-peptidase-IJournal of Antimicrobial Chemotherapy, 1996
- A Novel 1.BETA.-Methylcarbapenem Antibiotic, S-4661.Synthesis and Structure-activity Relationships of 2-(5-Substituted Pyrrolidin-3-ylthio)-1.BETA.-methylcarbapenems.The Journal of Antibiotics, 1996
- In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase IAntimicrobial Agents and Chemotherapy, 1991